Metropolitan Life Insurance Company (MetLife)’s Ingredion INGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,915
| Closed | -$1.15M | – | 2455 |
|
|
2021
Q4 | $1.15M | Sell |
11,915
-319
| -3% | -$30.7K | 0.02% | 872 |
|
|
2021
Q3 | $1.09M | Sell |
12,234
-422
| -3% | -$37.2K | 0.02% | 884 |
|
|
2021
Q2 | $1.15M | Sell |
12,656
-35
| -0.3% | -$3.27K | 0.02% | 906 |
|
|
2021
Q1 | $1.14M | Buy |
12,691
+677
| +6% | +$57.9K | 0.02% | 852 |
|
|
2020
Q4 | $945K | Sell |
12,014
-321
| -3% | -$24.8K | 0.01% | 911 |
|
|
2020
Q3 | $934K | Sell |
12,335
-652
| -5% | -$53K | 0.02% | 786 |
|
|
2020
Q2 | $1.08M | Sell |
12,987
-4,793
| -27% | -$392K | 0.02% | 693 |
|
|
2020
Q1 | $1.34M | Sell |
17,780
-965
| -5% | -$82.9K | 0.03% | 541 |
|
|
2019
Q4 | $1.74M | Buy |
18,745
+123
| +0.7% | +$10.3K | 0.03% | 610 |
|
|
2019
Q3 | $1.52M | Sell |
18,622
-433
| -2% | -$34.4K | 0.03% | 638 |
|
|
2019
Q2 | $1.57M | Buy |
19,055
+9
| +0% | +$774 | 0.03% | 643 |
|
|
2019
Q1 | $1.8M | Sell |
19,046
-1,196
| -6% | -$113K | 0.03% | 542 |
|
|
2018
Q4 | $1.85M | Sell |
20,242
-22
| -0.1% | -$2.2K | 0.04% | 471 |
|
|
2018
Q3 | $2.13M | Sell |
20,264
-563
| -3% | -$57.5K | 0.04% | 489 |
|
|
2018
Q2 | $2.31M | Buy |
20,827
+6
| +0% | +$706 | 0.04% | 440 |
|
|
2018
Q1 | $2.68M | Buy |
20,821
+250
| +1% | +$33.4K | 0.04% | 372 |
|
|
2017
Q4 | $2.88M | Sell |
20,571
-46,857
| -69% | -$6.18M | 0.04% | 349 |
|
|
2017
Q3 | $8.13M | Sell |
67,428
-30
| -0% | -$3.66K | 0.05% | 327 |
|
|
2017
Q2 | $8.04M | Sell |
67,458
-1,479
| -2% | -$176K | 0.06% | 323 |
|
|
2017
Q1 | $8.3M | Sell |
68,937
-727
| -1% | -$88.9K | 0.06% | 325 |
|
|
2016
Q4 | $8.71M | Sell |
69,664
-182
| -0.3% | -$23K | 0.06% | 296 |
|
|
2016
Q3 | $9.29M | Sell |
69,846
-83
| -0.1% | -$11.1K | 0.07% | 273 |
|
|
2016
Q2 | $9.05M | Buy |
69,929
+4,394
| +7% | +$511K | 0.07% | 276 |
|
|
2016
Q1 | $7M | Buy |
65,535
+2,133
| +3% | +$213K | 0.05% | 344 |
|
|
2015
Q4 | $6.08M | Buy |
63,402
+425
| +0.7% | +$40.3K | 0.05% | 408 |
|
|
2015
Q3 | $5.5M | Sell |
62,977
-701
| -1% | -$60.1K | 0.04% | 458 |
|
|
2015
Q2 | $5.08M | Buy |
63,678
+97
| +0.2% | +$7.79K | 0.04% | 536 |
|
|
2015
Q1 | $4.95M | Buy |
63,581
+1,890
| +3% | +$155K | 0.04% | 534 |
|
|
2014
Q4 | $5.23M | Sell |
61,691
-1,661
| -3% | -$132K | 0.04% | 517 |
|
|
2014
Q3 | $4.8M | Buy |
63,352
+466
| +0.7% | +$36.2K | 0.03% | 524 |
|
|
2014
Q2 | $4.72M | Buy |
62,886
+216
| +0.3% | +$15.7K | 0.03% | 574 |
|
|
2014
Q1 | $4.27M | Sell |
62,670
-547
| -0.9% | -$35.9K | 0.03% | 607 |
|
|
2013
Q4 | $4.33M | Sell |
63,217
-421
| -0.7% | -$28.5K | 0.03% | 584 |
|
|
2013
Q3 | $4.21M | Buy |
63,638
+888
| +1% | +$58K | 0.03% | 558 |
|
|
2013
Q2 | $4.12M | Buy |
+62,750
| New | +$4.41M | 0.03% | 519 |
|
Other funds holding INGR
YAM
CB
Metropolitan Life Insurance Company (MetLife)'s INGR Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Ingredion (INGR) in Q1 2022, closing a stake of 11,915 shares — an estimated $1.15M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in INGR in Q2 2013 and held it in 35 quarters. The position peaked at $9.29M in Q3 2016. 458 funds tracked by Wall St. Rank hold INGR as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Ingredion position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 11,915 Ingredion shares in Q1 2022, an estimated $1.15M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Ingredion in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Ingredion position peaked at $9.29M in Q3 2016.
- 458 funds tracked by Wall St. Rank held Ingredion as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.